XML 56 R20.htm IDEA: XBRL DOCUMENT
v3.23.2

GENERAL - Identifiable net assets of Gesher (Details) |  | 6 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | ---
Jan. 25, 2023 USD ($) $ / shares | Jun. 30, 2023 USD ($) Options | Dec. 31, 2022 Options | Jun. 30, 2022 Options | Dec. 31, 2021 Options | Dec. 31, 2020 Options
Disclosure of detailed information about biological assets [line items] |  |  |  |  |  |
Shares issued to Gesher shareholders | Options |  | 1,195,671 | 1,228,410 | 1,600,499 | 1,600,499 | 0
IFRS 2 Listing expenses (A+B-C) | $ 46,717,000 | $ 46,717,000 |  |  |  |
Gesher |  |  |  |  |  |
Disclosure of detailed information about biological assets [line items] |  |  |  |  |  |
Shares issued to Gesher shareholders | 4,287,156 |  |  |  |  |
Opening price of the Company's share on Nasdaq as of January 25, 2023 ($) | $ / shares | $ 10.23 |  |  |  |  |
(A) Fair value of the Company's shares issued to Gesher shareholders | $ 43,858,000 |  |  |  |  |
Opening price of the Company's warrants on Nasdaq as of January 25, 2023 ($) | $ / shares | $ 0.74 |  |  |  |  |
(B) Fair value of the Company's warrants issued to Gesher shareholders | $ 9,012,000 |  |  |  |  |
Gesher's cash in trust | 8,127,000 |  |  |  |  |
Gesher's liabilities | (1,974,000) |  |  |  |  |
(C) Net assets of Gesher | 6,153,000 |  |  |  |  |
IFRS 2 Listing expenses (A+B-C) | $ 46,717,000 |  |  |  |  |
Gesher | Warrants |  |  |  |  |  |
Disclosure of detailed information about biological assets [line items] |  |  |  |  |  |
Shares issued to Gesher shareholders | 12,250,000 |  |  |  |  |

X
- Definition The amount of fair value of shares. + References No definition available. + Details
Name: | crgo_FairValueOfSharesIssued
Namespace Prefix: | crgo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of fair value of warrants. + References No definition available. + Details
Name: | crgo_FairValueOfWarrantsIssued
Namespace Prefix: | crgo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The price of a single share of the stock of the company. + References No definition available. + Details
Name: | crgo_IfrsSharePrice
Namespace Prefix: | crgo_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount recognised as of the acquisition date for liabilities assumed in a business combination. + References No definition available. + Details
Name: | crgo_LiabilitiesRecognisedAsOfAcquisitionDate
Namespace Prefix: | crgo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of net assets recognized as of the acquisition date. + References No definition available. + Details
Name: | crgo_NetAssetsRecognisedAsOfAcquisitionDate
Namespace Prefix: | crgo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of share listing expenses. + References No definition available. + Details
Name: | crgo_ShareListingExpense
Namespace Prefix: | crgo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The price of warrant. + References No definition available. + Details
Name: | crgo_WarrantPrice
Namespace Prefix: | crgo_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 3 -IssueDate 2022-03-24 -Paragraph B64 -Subparagraph i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B -URIDate 2022-03-24 + Details
Name: | ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2022-03-24 -Paragraph B64 -Subparagraph f -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B -URIDate 2022-03-24 + Details
Name: | ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=crgo_GesherIAcquisitionCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=crgo_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |